Cargando…
Metabolomics Profiling of Cystic Renal Disease towards Biomarker Discovery
SIMPLE SUMMARY: Cystic renal disease (CRD) is a group of diseases characterized by abnormal sacs, or cysts, in the kidneys. CRD can be detected using certain imaging modalities (i.e., ultrasound). Patients with CRD might be symptoms-free, while others can show symptoms long after cysts development....
Autores principales: | Sriwi, Dalia, Alabdaljabar, Mohamad S., Jacob, Minnie, Mujamammi, Ahmed H., Gu, Xinyun, Sabi, Essa M., Li, Liang, Hussein, Maged H., Dasouki, Majed, Abdel Rahman, Anas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389671/ https://www.ncbi.nlm.nih.gov/pubmed/34440002 http://dx.doi.org/10.3390/biology10080770 |
Ejemplares similares
-
Metabolomics Profiling of Nephrotic Syndrome towards Biomarker Discovery
por: Jacob, Minnie, et al.
Publicado: (2022) -
Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients
por: Dahabiyeh, Lina A., et al.
Publicado: (2023) -
Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical Isotope Labeling LC-MS Analysis
por: Dahabiyeh, Lina A., et al.
Publicado: (2020) -
Metabolomics Distinguishes DOCK8 Deficiency from Atopic Dermatitis: Towards a Biomarker Discovery
por: Jacob, Minnie, et al.
Publicado: (2019) -
Metabolomics Based Profiling of Dexamethasone Side Effects in Rats
por: Malkawi, Abeer K., et al.
Publicado: (2018)